Table 1 Baseline characteristics of the patients by neutrophil-to-high density lipoprotein cholesterol ratio.

Demographics

 Age, year, mean (SD)

56.75 (14.58)

58.50 (14.69)

55.10 (14.28)

 < 0.001

 Female, n (%)

1,769 (35.4)

968 (40.0)

801 (31.0)

 < 0.001

Smoking, n (%)

1,338 (26.7)

586 (24.2)

752 (29.1)

 < 0.001

Alcohol, n (%)

1,605 (32.1)

751 (31.0)

854 (33.0)

0.134

Medical history, n (%)

 Hypertension

3,615 (72.2)

1,682 (69.5)

1,933 (74.8)

 < 0.001

 Diabetes

553 (11.1)

248 (10.2)

305 (11.8)

0.088

 Chronic kidney disease

147 ( 2.9)

75 (3.1)

72 (2.8)

0.568

Hematoma characteristics, n (%)

 Size of hematoma, cm, mean (SD)

22.40 (27.32)

17.84 (23.59)

26.74 (29.81)

 < 0.001

 Infratentorial hematoma, n (%)

994 (19.9)

438 (18.1)

556 (21.5)

0.003

 Intraventricular hematoma, n (%)

1,045 (20.9)

415 (17.1)

630 (24.4)

 < 0.001

Glasgow coma score, n (%)

 3–8

1,689 (33.8)

448 (18.5)

1,241 (48.0)

 < 0.001

 9–15

3,282 (65.6)

1,959 (81.0)

1,323 (51.2)

SBP, mean (SD)

159.04 (31.83)

155.26 (29.28)

162.57 (33.68)

 < 0.001

Antithrombotic therapy, n (%)

413 (8.3)

228 (9.4)

185 (7.2)

 < 0.001

Laboratory tests

 Albumin, g/L, mean (SD)

38.20 (6.07)

39.14 (5.16)

37.31 (6.70)

 < 0.001

 Lymphocyte, 10⁹/L, mean (SD)

1.10 (0.66)

1.15 (0.61)

1.06 (0.69)

 < 0.001

 Neutrophil, 10⁹/L, mean (SD)

8.95 (5.01)

6.02 (2.43)

11.69 (5.25)

 < 0.001

 White blood cell, 10⁹/L, mean (SD)

10.91 (10.46)

7.79 (4.01)

13.84 (13.39)

 < 0.001

 Platelets, 10⁹/L, mean (SD)

162.38 (73.48)

154.02 (64.29)

169.21 (79.44)

 < 0.001

 Glucose, mmol/L, mean (SD)

7.47 (3.14)

6.73 (2.59)

8.16 (3.44)

 < 0.001

 High-density lipoprotein, mmol/L, mean (SD)

1.27 (0.45)

1.46 (0.45)

1.09 (0.37)

 < 0.001

 Activated partial thromboplastin time, s, mean (SD)

28.81 (8.49)

28.19 (7.34)

29.37 (9.37)

 < 0.001